Alps Advisors Inc Syndax Pharmaceuticals Inc Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

A detailed history of Alps Advisors Inc transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Alps Advisors Inc holds 66,403 shares of SNDX stock, worth $868,551. This represents 0.01% of its overall portfolio holdings.

Number of Shares

66,403

Previous 66,293 0.17%

Holding current value

$868,551

Previous $1.36 Million 6.03%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$17.93 - $24.81 $1,972 - $2,729	110 Added 0.17%	66,403 $1.28 Million
Q2 2024 Aug 13, 2024	BUY	$18.82 - $23.79 $119,864 - $151,518	6,369 Added 10.63%	66,293 $1.36 Million
Q1 2024 May 14, 2024	BUY	$19.71 - $24.57 $232,538 - $289,876	11,798 Added 24.51%	59,924 $1.43 Million
Q4 2023 Feb 14, 2024	SELL	$11.39 - $21.67 $35,422 - $67,393	-3,110 Reduced 6.07%	48,126 $1.04 Million
Q3 2023 Nov 14, 2023	BUY	$14.52 - $21.77 $9,452 - $14,172	651 Added 1.29%	51,236 $743,000
Q2 2023 Aug 14, 2023	BUY	$19.35 - $22.31 $106,347 - $122,615	5,496 Added 12.19%	50,585 $1.06 Million
Q1 2023 May 10, 2023	SELL	$20.66 - $28.98 $6,549 - $9,186	-317 Reduced 0.7%	45,089 $952,000
Q4 2022 Feb 14, 2023	BUY	$20.64 - $26.24 $300,394 - $381,896	14,554 Added 47.17%	45,406 $1.16 Million
Q3 2022 Nov 14, 2022	SELL	$18.51 - $24.79 $46,349 - $62,074	-2,504 Reduced 7.51%	30,852 $741,000
Q2 2022 Aug 11, 2022	SELL	$13.64 - $19.48 $316,175 - $451,546	-23,180 Reduced 41.0%	33,356 $642,000
Q1 2022 May 16, 2022	SELL	$14.84 - $22.15 $24,382 - $36,392	-1,643 Reduced 2.82%	56,536 $983,000
Q4 2021 Feb 09, 2022	SELL	$15.23 - $22.47 $21,535 - $31,772	-1,414 Reduced 2.37%	58,179 $1.27 Million
Q3 2021 Nov 15, 2021	SELL	$13.87 - $19.8 $54,758 - $78,170	-3,948 Reduced 6.21%	59,593 $1.14 Million
Q2 2021 Aug 11, 2021	BUY	$13.42 - $25.18 $852,720 - $1.6 Million	63,541 New	63,541 $1.09 Million
Q4 2018 Feb 04, 2019	SELL	$3.6 - $8.42 $148,780 - $347,981	-41,328 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$6.33 - $8.08 $34,669 - $44,254	5,477 Added 15.28%	41,328 $334,000
Q2 2018 Aug 02, 2018	BUY	$6.93 - $14.63 $61,157 - $129,109	8,825 Added 32.65%	35,851 $252,000
Q2 2018 Jul 25, 2018	SELL	$6.93 - $14.63 $39,403 - $83,186	-5,686 Reduced 17.38%	27,026 $237,000
Q1 2018 May 01, 2018	BUY	$8.71 - $14.82 $49,525 - $84,266	5,686 Added 21.04%	32,712 $465,000
Q4 2017 Feb 05, 2018	BUY	$7.8 - $12.94 $40,115 - $66,550	5,143 Added 23.5%	27,026 $237,000
Q3 2017 Nov 03, 2017	BUY	$10.9 - $12.73 $238,524 - $278,570	21,883	21,883 $256,000

Others Institutions Holding SNDX

# of Institutions

228

Shares Held

88.4M

Call Options Held

1.01M

Put Options Held

692K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $740M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Syndax Pharmaceuticals Inc Transaction History